Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008
about
Frailty, HIV infection, and mortality in an aging cohort of injection drug usersIncreases in CD4+ T-cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada.Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort studyTiming of antiretroviral therapy initiation in a nationally representative sample of HIV-infected adults receiving medical care in the United States.Antiretroviral therapy: a promising HIV prevention strategy?The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable PopulationsLevel of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART)Challenges in managing HIV in people who use drugsCurrent and emerging research needs in studying the NYC HIV-drug use epidemic.Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapyImpact of generic antiretroviral therapy (ART) and free ART programs on time to initiation of ART at a tertiary HIV care center in Chennai, India.Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009.Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia.Comprehensive Approaches to the Diagnosis and Treatment of HIV Infection in the Community: Can "Seek and Treat" Really Deliver?
P2860
Q28485898-CA4BD321-9E3B-4F98-9AAC-7DB6F4759E07Q30399058-179E5CA5-E7C1-4D6D-BF96-7101CFF7A543Q34062890-F4D86BA4-8ABB-424F-90C7-8123D3AF5FABQ34606589-58E383D6-1D47-4920-98D9-AFD1507856E2Q34781053-DCD0AE36-95A7-44E4-926B-8069B3FEBFB7Q35054628-8892A470-35E6-4962-A633-67D0685AFD84Q35371056-CA5C11BB-B416-4825-BF64-9E512309A4DDQ35538674-C569F1F0-4501-4697-9299-7424EAB1273CQ35683951-6AF850D3-066C-4CB8-9429-A43242A7B5B2Q35835854-62F28D48-72D6-4579-B5CD-33E5ABE63468Q35996628-4A4B4EAB-4272-4850-96CA-C51FFF1DF485Q37042436-9590398F-D508-49F8-95EC-FDCF1D45A862Q38428765-DF8FA0DD-C258-416D-B755-A73E910A299EQ42208893-7DB9C3DB-4925-406E-86B7-3BBCDBFB2948Q45363060-39766FE2-4FFC-4457-A996-75E8962704B3Q50116350-EDEDEF55-BE90-472E-B24F-271DB48AC1D2
P2860
Temporal trends in highly active antiretroviral therapy initiation among injection drug users in Baltimore, Maryland, 1996-2008
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Temporal trends in highly acti ...... Baltimore, Maryland, 1996-2008
@ast
Temporal trends in highly acti ...... Baltimore, Maryland, 1996-2008
@en
type
label
Temporal trends in highly acti ...... Baltimore, Maryland, 1996-2008
@ast
Temporal trends in highly acti ...... Baltimore, Maryland, 1996-2008
@en
prefLabel
Temporal trends in highly acti ...... Baltimore, Maryland, 1996-2008
@ast
Temporal trends in highly acti ...... Baltimore, Maryland, 1996-2008
@en
P2093
P2860
P356
P1476
Temporal trends in highly acti ...... Baltimore, Maryland, 1996-2008
@en
P2093
Gregory D Kirk
Jacquie Astemborski
Noya Galai
Shruti H Mehta
P2860
P304
P356
10.1086/652867
P407
P577
2010-06-01T00:00:00Z